Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic, irreversible, progressively destructive lung disease that culminates in respiratory failure and death. Randomised controlled trials have demonstrated that treatment of IPF patients with pirfenidone reduces lung function decline, improves progression-...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2015-03-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/24/135/58.full.pdf+html |